nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—head and neck cancer—stomach cancer	0.241	0.568	CtDrD
Docetaxel—pancreatic cancer—stomach cancer	0.183	0.432	CtDrD
Docetaxel—EGFR—stomach cancer	0.13	1	CbGaD
Docetaxel—ABCC10—Doxorubicin—stomach cancer	0.0199	0.0889	CbGbCtD
Docetaxel—ABCC10—Methotrexate—stomach cancer	0.0192	0.0861	CbGbCtD
Docetaxel—SLC22A7—Fluorouracil—stomach cancer	0.0172	0.0768	CbGbCtD
Docetaxel—ABCC1—Epirubicin—stomach cancer	0.0144	0.0646	CbGbCtD
Docetaxel—ABCC1—Irinotecan—stomach cancer	0.014	0.0628	CbGbCtD
Docetaxel—ABCB1—Mitomycin—stomach cancer	0.0132	0.0591	CbGbCtD
Docetaxel—CYP1B1—Doxorubicin—stomach cancer	0.0108	0.0483	CbGbCtD
Docetaxel—SLCO1B3—Methotrexate—stomach cancer	0.0107	0.0481	CbGbCtD
Docetaxel—ABCC2—Irinotecan—stomach cancer	0.0104	0.0465	CbGbCtD
Docetaxel—SLC22A7—Methotrexate—stomach cancer	0.00946	0.0423	CbGbCtD
Docetaxel—ABCG2—Irinotecan—stomach cancer	0.0094	0.042	CbGbCtD
Docetaxel—ABCG2—Fluorouracil—stomach cancer	0.00902	0.0403	CbGbCtD
Docetaxel—ABCC1—Doxorubicin—stomach cancer	0.00767	0.0343	CbGbCtD
Docetaxel—ABCC1—Methotrexate—stomach cancer	0.00743	0.0332	CbGbCtD
Docetaxel—CYP3A7—Irinotecan—stomach cancer	0.00694	0.031	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.00694	0.031	CbGbCtD
Docetaxel—ABCC2—Doxorubicin—stomach cancer	0.00568	0.0254	CbGbCtD
Docetaxel—ABCC2—Methotrexate—stomach cancer	0.0055	0.0246	CbGbCtD
Docetaxel—CYP3A5—Irinotecan—stomach cancer	0.00521	0.0233	CbGbCtD
Docetaxel—ABCG2—Doxorubicin—stomach cancer	0.00513	0.023	CbGbCtD
Docetaxel—ABCG2—Methotrexate—stomach cancer	0.00497	0.0222	CbGbCtD
Docetaxel—ABCB1—Irinotecan—stomach cancer	0.00339	0.0152	CbGbCtD
Docetaxel—CYP3A4—Irinotecan—stomach cancer	0.00203	0.00908	CbGbCtD
Docetaxel—ABCB1—Doxorubicin—stomach cancer	0.00185	0.00828	CbGbCtD
Docetaxel—ABCB1—Methotrexate—stomach cancer	0.00179	0.00802	CbGbCtD
Docetaxel—ABCC2—bile—stomach cancer	0.0016	0.0446	CbGeAlD
Docetaxel—KIF11—Topotecan—Irinotecan—stomach cancer	0.00152	1	CbGdCrCtD
Docetaxel—CYP3A4—Doxorubicin—stomach cancer	0.00111	0.00496	CbGbCtD
Docetaxel—GHRHR—endocrine gland—stomach cancer	0.000961	0.0267	CbGeAlD
Docetaxel—KIF11—bone marrow—stomach cancer	0.000912	0.0254	CbGeAlD
Docetaxel—NR1I2—digestive system—stomach cancer	0.000697	0.0194	CbGeAlD
Docetaxel—TUBB3—hematopoietic system—stomach cancer	0.000655	0.0182	CbGeAlD
Docetaxel—MAP4—hematopoietic system—stomach cancer	0.000655	0.0182	CbGeAlD
Docetaxel—TUBB1—hematopoietic system—stomach cancer	0.000641	0.0178	CbGeAlD
Docetaxel—BCL2—hematopoietic system—stomach cancer	0.000596	0.0166	CbGeAlD
Docetaxel—NR1I2—endocrine gland—stomach cancer	0.000576	0.016	CbGeAlD
Docetaxel—KIF11—lymph node—stomach cancer	0.000565	0.0157	CbGeAlD
Docetaxel—BCL2—epithelium—stomach cancer	0.000545	0.0151	CbGeAlD
Docetaxel—MAP4—pancreas—stomach cancer	0.000534	0.0148	CbGeAlD
Docetaxel—BCL2—smooth muscle tissue—stomach cancer	0.000525	0.0146	CbGeAlD
Docetaxel—NR1I2—liver—stomach cancer	0.000519	0.0144	CbGeAlD
Docetaxel—MAP2—hematopoietic system—stomach cancer	0.000516	0.0144	CbGeAlD
Docetaxel—TUBB3—lymphoid tissue—stomach cancer	0.000461	0.0128	CbGeAlD
Docetaxel—MAP4—lymphoid tissue—stomach cancer	0.000461	0.0128	CbGeAlD
Docetaxel—TUBB3—digestive system—stomach cancer	0.000456	0.0127	CbGeAlD
Docetaxel—MAP4—digestive system—stomach cancer	0.000456	0.0127	CbGeAlD
Docetaxel—MAP2—pancreas—stomach cancer	0.00042	0.0117	CbGeAlD
Docetaxel—BCL2—lymphoid tissue—stomach cancer	0.00042	0.0117	CbGeAlD
Docetaxel—BCL2—digestive system—stomach cancer	0.000414	0.0115	CbGeAlD
Docetaxel—TUBB1—bone marrow—stomach cancer	0.000411	0.0114	CbGeAlD
Docetaxel—TUBB4A—hematopoietic system—stomach cancer	0.000399	0.0111	CbGeAlD
Docetaxel—BCL2—bone marrow—stomach cancer	0.000382	0.0106	CbGeAlD
Docetaxel—MAP4—endocrine gland—stomach cancer	0.000377	0.0105	CbGeAlD
Docetaxel—TUBB2A—hematopoietic system—stomach cancer	0.000363	0.0101	CbGeAlD
Docetaxel—MAP2—digestive system—stomach cancer	0.000359	0.00998	CbGeAlD
Docetaxel—TUBB6—hematopoietic system—stomach cancer	0.000358	0.00996	CbGeAlD
Docetaxel—BCL2—endocrine gland—stomach cancer	0.000342	0.00952	CbGeAlD
Docetaxel—MAP4—liver—stomach cancer	0.00034	0.00945	CbGeAlD
Docetaxel—MAPT—lymph node—stomach cancer	0.000331	0.00921	CbGeAlD
Docetaxel—SLCO1B3—endocrine gland—stomach cancer	0.00033	0.00917	CbGeAlD
Docetaxel—TUBB6—epithelium—stomach cancer	0.000327	0.0091	CbGeAlD
Docetaxel—TUBB4A—pancreas—stomach cancer	0.000325	0.00903	CbGeAlD
Docetaxel—TUBB—smooth muscle tissue—stomach cancer	0.000321	0.00894	CbGeAlD
Docetaxel—TUBB2A—smooth muscle tissue—stomach cancer	0.00032	0.00889	CbGeAlD
Docetaxel—TUBB6—smooth muscle tissue—stomach cancer	0.000315	0.00877	CbGeAlD
Docetaxel—TUBB2B—pancreas—stomach cancer	0.000314	0.00873	CbGeAlD
Docetaxel—ABCC10—hematopoietic system—stomach cancer	0.000313	0.00872	CbGeAlD
Docetaxel—TUBB4B—hematopoietic system—stomach cancer	0.000311	0.00865	CbGeAlD
Docetaxel—SLC22A7—digestive system—stomach cancer	0.00031	0.00863	CbGeAlD
Docetaxel—EGFR—liver—stomach cancer	0.000305	0.00848	CbGeAlD
Docetaxel—SLCO1B3—liver—stomach cancer	0.000297	0.00827	CbGeAlD
Docetaxel—TUBB—pancreas—stomach cancer	0.000297	0.00826	CbGeAlD
Docetaxel—MAP2—endocrine gland—stomach cancer	0.000297	0.00825	CbGeAlD
Docetaxel—TUBB2A—pancreas—stomach cancer	0.000296	0.00822	CbGeAlD
Docetaxel—TUBB6—pancreas—stomach cancer	0.000291	0.00811	CbGeAlD
Docetaxel—TUBB4A—lymphoid tissue—stomach cancer	0.000281	0.00781	CbGeAlD
Docetaxel—CYP3A7—endocrine gland—stomach cancer	0.000278	0.00774	CbGeAlD
Docetaxel—TUBB4A—digestive system—stomach cancer	0.000277	0.00772	CbGeAlD
Docetaxel—TUBB4B—smooth muscle tissue—stomach cancer	0.000274	0.00762	CbGeAlD
Docetaxel—TUBB2B—digestive system—stomach cancer	0.000268	0.00746	CbGeAlD
Docetaxel—MAP2—liver—stomach cancer	0.000267	0.00744	CbGeAlD
Docetaxel—MAP4—lymph node—stomach cancer	0.00026	0.00724	CbGeAlD
Docetaxel—SLC22A7—endocrine gland—stomach cancer	0.000256	0.00713	CbGeAlD
Docetaxel—TUBB4B—pancreas—stomach cancer	0.000253	0.00705	CbGeAlD
Docetaxel—TUBB2A—digestive system—stomach cancer	0.000252	0.00702	CbGeAlD
Docetaxel—TUBB6—lymphoid tissue—stomach cancer	0.000252	0.00701	CbGeAlD
Docetaxel—CYP3A7—liver—stomach cancer	0.000251	0.00697	CbGeAlD
Docetaxel—TUBB6—digestive system—stomach cancer	0.000249	0.00692	CbGeAlD
Docetaxel—CYP1B1—hematopoietic system—stomach cancer	0.000246	0.00685	CbGeAlD
Docetaxel—BCL2—lymph node—stomach cancer	0.000237	0.00658	CbGeAlD
Docetaxel—EGFR—lymph node—stomach cancer	0.000234	0.0065	CbGeAlD
Docetaxel—TUBB—bone marrow—stomach cancer	0.000234	0.0065	CbGeAlD
Docetaxel—TUBB2A—bone marrow—stomach cancer	0.000233	0.00647	CbGeAlD
Docetaxel—SLC22A7—liver—stomach cancer	0.000231	0.00643	CbGeAlD
Docetaxel—TUBB6—bone marrow—stomach cancer	0.000229	0.00638	CbGeAlD
Docetaxel—TUBB4A—endocrine gland—stomach cancer	0.000229	0.00638	CbGeAlD
Docetaxel—TUBB2B—endocrine gland—stomach cancer	0.000222	0.00616	CbGeAlD
Docetaxel—ABCC10—lymphoid tissue—stomach cancer	0.000221	0.00614	CbGeAlD
Docetaxel—TUBB4B—lymphoid tissue—stomach cancer	0.000219	0.00609	CbGeAlD
Docetaxel—ABCC10—digestive system—stomach cancer	0.000218	0.00606	CbGeAlD
Docetaxel—CYP1B1—smooth muscle tissue—stomach cancer	0.000217	0.00604	CbGeAlD
Docetaxel—TUBB4B—digestive system—stomach cancer	0.000216	0.00602	CbGeAlD
Docetaxel—CYP3A7-CYP3A51P—liver—stomach cancer	0.000213	0.00593	CbGeAlD
Docetaxel—TUBB2A—endocrine gland—stomach cancer	0.000209	0.0058	CbGeAlD
Docetaxel—TUBB4A—liver—stomach cancer	0.000207	0.00575	CbGeAlD
Docetaxel—TUBB6—endocrine gland—stomach cancer	0.000206	0.00572	CbGeAlD
Docetaxel—MAP2—lymph node—stomach cancer	0.000205	0.0057	CbGeAlD
Docetaxel—ABCC10—bone marrow—stomach cancer	0.000201	0.00559	CbGeAlD
Docetaxel—TUBB4B—bone marrow—stomach cancer	0.000199	0.00555	CbGeAlD
Docetaxel—TUBB—liver—stomach cancer	0.000189	0.00526	CbGeAlD
Docetaxel—TUBB2A—liver—stomach cancer	0.000188	0.00523	CbGeAlD
Docetaxel—TUBB6—liver—stomach cancer	0.000185	0.00516	CbGeAlD
Docetaxel—ABCC10—endocrine gland—stomach cancer	0.00018	0.00501	CbGeAlD
Docetaxel—TUBB4B—endocrine gland—stomach cancer	0.000179	0.00497	CbGeAlD
Docetaxel—ABCC2—digestive system—stomach cancer	0.000175	0.00487	CbGeAlD
Docetaxel—CYP1B1—lymphoid tissue—stomach cancer	0.000174	0.00483	CbGeAlD
Docetaxel—CYP1B1—digestive system—stomach cancer	0.000171	0.00477	CbGeAlD
Docetaxel—CYP3A5—hematopoietic system—stomach cancer	0.00017	0.00474	CbGeAlD
Docetaxel—ABCB1—blood vessel—stomach cancer	0.00017	0.00473	CbGeAlD
Docetaxel—ABCC10—liver—stomach cancer	0.000162	0.00452	CbGeAlD
Docetaxel—TUBB4B—liver—stomach cancer	0.000161	0.00448	CbGeAlD
Docetaxel—TUBB4A—lymph node—stomach cancer	0.000158	0.00441	CbGeAlD
Docetaxel—TUBB2B—lymph node—stomach cancer	0.000153	0.00426	CbGeAlD
Docetaxel—TUBB—lymph node—stomach cancer	0.000145	0.00403	CbGeAlD
Docetaxel—ABCC2—endocrine gland—stomach cancer	0.000145	0.00402	CbGeAlD
Docetaxel—TUBB2A—lymph node—stomach cancer	0.000144	0.00401	CbGeAlD
Docetaxel—TUBB6—lymph node—stomach cancer	0.000142	0.00395	CbGeAlD
Docetaxel—CYP1B1—endocrine gland—stomach cancer	0.000142	0.00394	CbGeAlD
Docetaxel—CYP3A5—pancreas—stomach cancer	0.000139	0.00386	CbGeAlD
Docetaxel—ABCC2—liver—stomach cancer	0.00013	0.00363	CbGeAlD
Docetaxel—CYP3A4—hematopoietic system—stomach cancer	0.000128	0.00356	CbGeAlD
Docetaxel—CYP1B1—liver—stomach cancer	0.000128	0.00355	CbGeAlD
Docetaxel—ABCC10—lymph node—stomach cancer	0.000124	0.00346	CbGeAlD
Docetaxel—TUBB4B—lymph node—stomach cancer	0.000124	0.00344	CbGeAlD
Docetaxel—CYP3A5—digestive system—stomach cancer	0.000118	0.00329	CbGeAlD
Docetaxel—ABCG2—bone marrow—stomach cancer	0.000118	0.00327	CbGeAlD
Docetaxel—ABCC1—liver—stomach cancer	0.000115	0.00319	CbGeAlD
Docetaxel—ABCC2—lymph node—stomach cancer	0.0001	0.00278	CbGeAlD
Docetaxel—CYP1B1—lymph node—stomach cancer	9.79e-05	0.00272	CbGeAlD
Docetaxel—CYP3A5—endocrine gland—stomach cancer	9.79e-05	0.00272	CbGeAlD
Docetaxel—ABCG2—liver—stomach cancer	9.51e-05	0.00264	CbGeAlD
Docetaxel—ABCB1—hematopoietic system—stomach cancer	9.05e-05	0.00252	CbGeAlD
Docetaxel—CYP3A4—digestive system—stomach cancer	8.89e-05	0.00247	CbGeAlD
Docetaxel—CYP3A5—liver—stomach cancer	8.83e-05	0.00245	CbGeAlD
Docetaxel—ABCC1—lymph node—stomach cancer	8.81e-05	0.00245	CbGeAlD
Docetaxel—ABCB1—epithelium—stomach cancer	8.27e-05	0.0023	CbGeAlD
Docetaxel—ABCB1—pancreas—stomach cancer	7.37e-05	0.00205	CbGeAlD
Docetaxel—CYP3A4—endocrine gland—stomach cancer	7.35e-05	0.00204	CbGeAlD
Docetaxel—ABCG2—lymph node—stomach cancer	7.29e-05	0.00203	CbGeAlD
Docetaxel—CYP3A4—liver—stomach cancer	6.62e-05	0.00184	CbGeAlD
Docetaxel—ABCB1—lymphoid tissue—stomach cancer	6.37e-05	0.00177	CbGeAlD
Docetaxel—ABCB1—digestive system—stomach cancer	6.29e-05	0.00175	CbGeAlD
Docetaxel—ABCB1—bone marrow—stomach cancer	5.8e-05	0.00161	CbGeAlD
Docetaxel—ABCB1—endocrine gland—stomach cancer	5.2e-05	0.00145	CbGeAlD
Docetaxel—ABCB1—liver—stomach cancer	4.69e-05	0.0013	CbGeAlD
Docetaxel—ABCB1—lymph node—stomach cancer	3.59e-05	0.001	CbGeAlD
Docetaxel—Shock—Capecitabine—stomach cancer	2.51e-05	0.000241	CcSEcCtD
Docetaxel—Rhinitis—Epirubicin—stomach cancer	2.51e-05	0.000241	CcSEcCtD
Docetaxel—Conjunctivitis—Doxorubicin—stomach cancer	2.51e-05	0.000241	CcSEcCtD
Docetaxel—Nervous system disorder—Capecitabine—stomach cancer	2.5e-05	0.000241	CcSEcCtD
Docetaxel—Haemorrhage—Epirubicin—stomach cancer	2.5e-05	0.000241	CcSEcCtD
Docetaxel—Hepatitis—Epirubicin—stomach cancer	2.5e-05	0.000241	CcSEcCtD
Docetaxel—Eye disorder—Methotrexate—stomach cancer	2.5e-05	0.00024	CcSEcCtD
Docetaxel—Diarrhoea—Fluorouracil—stomach cancer	2.5e-05	0.00024	CcSEcCtD
Docetaxel—Thrombocytopenia—Capecitabine—stomach cancer	2.5e-05	0.00024	CcSEcCtD
Docetaxel—Tachycardia—Capecitabine—stomach cancer	2.49e-05	0.000239	CcSEcCtD
Docetaxel—Hypoaesthesia—Epirubicin—stomach cancer	2.49e-05	0.000239	CcSEcCtD
Docetaxel—Pharyngitis—Epirubicin—stomach cancer	2.48e-05	0.000239	CcSEcCtD
Docetaxel—Cardiac disorder—Methotrexate—stomach cancer	2.48e-05	0.000239	CcSEcCtD
Docetaxel—Skin disorder—Capecitabine—stomach cancer	2.48e-05	0.000238	CcSEcCtD
Docetaxel—Urinary tract disorder—Epirubicin—stomach cancer	2.47e-05	0.000238	CcSEcCtD
Docetaxel—Oedema peripheral—Epirubicin—stomach cancer	2.46e-05	0.000237	CcSEcCtD
Docetaxel—Connective tissue disorder—Epirubicin—stomach cancer	2.46e-05	0.000236	CcSEcCtD
Docetaxel—Urethral disorder—Epirubicin—stomach cancer	2.45e-05	0.000236	CcSEcCtD
Docetaxel—Hepatobiliary disease—Doxorubicin—stomach cancer	2.44e-05	0.000235	CcSEcCtD
Docetaxel—Epistaxis—Doxorubicin—stomach cancer	2.43e-05	0.000234	CcSEcCtD
Docetaxel—Anorexia—Capecitabine—stomach cancer	2.43e-05	0.000234	CcSEcCtD
Docetaxel—Angiopathy—Methotrexate—stomach cancer	2.42e-05	0.000233	CcSEcCtD
Docetaxel—Vomiting—Irinotecan—stomach cancer	2.42e-05	0.000233	CcSEcCtD
Docetaxel—Immune system disorder—Methotrexate—stomach cancer	2.41e-05	0.000232	CcSEcCtD
Docetaxel—Dizziness—Fluorouracil—stomach cancer	2.41e-05	0.000232	CcSEcCtD
Docetaxel—Visual impairment—Epirubicin—stomach cancer	2.41e-05	0.000232	CcSEcCtD
Docetaxel—Mediastinal disorder—Methotrexate—stomach cancer	2.41e-05	0.000232	CcSEcCtD
Docetaxel—Agranulocytosis—Doxorubicin—stomach cancer	2.41e-05	0.000231	CcSEcCtD
Docetaxel—Rash—Irinotecan—stomach cancer	2.4e-05	0.000231	CcSEcCtD
Docetaxel—Dermatitis—Irinotecan—stomach cancer	2.4e-05	0.000231	CcSEcCtD
Docetaxel—Chills—Methotrexate—stomach cancer	2.4e-05	0.000231	CcSEcCtD
Docetaxel—Headache—Irinotecan—stomach cancer	2.39e-05	0.00023	CcSEcCtD
Docetaxel—Hypotension—Capecitabine—stomach cancer	2.38e-05	0.000229	CcSEcCtD
Docetaxel—Erythema multiforme—Epirubicin—stomach cancer	2.36e-05	0.000227	CcSEcCtD
Docetaxel—Alopecia—Methotrexate—stomach cancer	2.36e-05	0.000227	CcSEcCtD
Docetaxel—Mental disorder—Methotrexate—stomach cancer	2.34e-05	0.000225	CcSEcCtD
Docetaxel—Eye disorder—Epirubicin—stomach cancer	2.34e-05	0.000225	CcSEcCtD
Docetaxel—Malnutrition—Methotrexate—stomach cancer	2.33e-05	0.000224	CcSEcCtD
Docetaxel—Erythema—Methotrexate—stomach cancer	2.33e-05	0.000224	CcSEcCtD
Docetaxel—Haemoglobin—Doxorubicin—stomach cancer	2.33e-05	0.000224	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Capecitabine—stomach cancer	2.32e-05	0.000224	CcSEcCtD
Docetaxel—Cardiac disorder—Epirubicin—stomach cancer	2.32e-05	0.000223	CcSEcCtD
Docetaxel—Flushing—Epirubicin—stomach cancer	2.32e-05	0.000223	CcSEcCtD
Docetaxel—Vomiting—Fluorouracil—stomach cancer	2.32e-05	0.000223	CcSEcCtD
Docetaxel—Rhinitis—Doxorubicin—stomach cancer	2.32e-05	0.000223	CcSEcCtD
Docetaxel—Haemorrhage—Doxorubicin—stomach cancer	2.31e-05	0.000223	CcSEcCtD
Docetaxel—Hepatitis—Doxorubicin—stomach cancer	2.31e-05	0.000223	CcSEcCtD
Docetaxel—Insomnia—Capecitabine—stomach cancer	2.31e-05	0.000222	CcSEcCtD
Docetaxel—Hypoaesthesia—Doxorubicin—stomach cancer	2.3e-05	0.000221	CcSEcCtD
Docetaxel—Rash—Fluorouracil—stomach cancer	2.3e-05	0.000221	CcSEcCtD
Docetaxel—Dermatitis—Fluorouracil—stomach cancer	2.3e-05	0.000221	CcSEcCtD
Docetaxel—Pharyngitis—Doxorubicin—stomach cancer	2.3e-05	0.000221	CcSEcCtD
Docetaxel—Paraesthesia—Capecitabine—stomach cancer	2.29e-05	0.00022	CcSEcCtD
Docetaxel—Headache—Fluorouracil—stomach cancer	2.29e-05	0.00022	CcSEcCtD
Docetaxel—Urinary tract disorder—Doxorubicin—stomach cancer	2.29e-05	0.00022	CcSEcCtD
Docetaxel—Oedema peripheral—Doxorubicin—stomach cancer	2.28e-05	0.000219	CcSEcCtD
Docetaxel—Dysgeusia—Methotrexate—stomach cancer	2.28e-05	0.000219	CcSEcCtD
Docetaxel—Connective tissue disorder—Doxorubicin—stomach cancer	2.27e-05	0.000219	CcSEcCtD
Docetaxel—Dyspnoea—Capecitabine—stomach cancer	2.27e-05	0.000219	CcSEcCtD
Docetaxel—Angiopathy—Epirubicin—stomach cancer	2.27e-05	0.000218	CcSEcCtD
Docetaxel—Urethral disorder—Doxorubicin—stomach cancer	2.27e-05	0.000218	CcSEcCtD
Docetaxel—Nausea—Irinotecan—stomach cancer	2.26e-05	0.000218	CcSEcCtD
Docetaxel—Immune system disorder—Epirubicin—stomach cancer	2.26e-05	0.000217	CcSEcCtD
Docetaxel—Mediastinal disorder—Epirubicin—stomach cancer	2.25e-05	0.000217	CcSEcCtD
Docetaxel—Back pain—Methotrexate—stomach cancer	2.25e-05	0.000216	CcSEcCtD
Docetaxel—Dyspepsia—Capecitabine—stomach cancer	2.25e-05	0.000216	CcSEcCtD
Docetaxel—Chills—Epirubicin—stomach cancer	2.24e-05	0.000216	CcSEcCtD
Docetaxel—Arrhythmia—Epirubicin—stomach cancer	2.23e-05	0.000215	CcSEcCtD
Docetaxel—Visual impairment—Doxorubicin—stomach cancer	2.23e-05	0.000215	CcSEcCtD
Docetaxel—Decreased appetite—Capecitabine—stomach cancer	2.22e-05	0.000213	CcSEcCtD
Docetaxel—Alopecia—Epirubicin—stomach cancer	2.21e-05	0.000213	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Capecitabine—stomach cancer	2.2e-05	0.000212	CcSEcCtD
Docetaxel—Fatigue—Capecitabine—stomach cancer	2.2e-05	0.000212	CcSEcCtD
Docetaxel—Mental disorder—Epirubicin—stomach cancer	2.19e-05	0.000211	CcSEcCtD
Docetaxel—Erythema multiforme—Doxorubicin—stomach cancer	2.19e-05	0.00021	CcSEcCtD
Docetaxel—Constipation—Capecitabine—stomach cancer	2.18e-05	0.00021	CcSEcCtD
Docetaxel—Pain—Capecitabine—stomach cancer	2.18e-05	0.00021	CcSEcCtD
Docetaxel—Malnutrition—Epirubicin—stomach cancer	2.18e-05	0.000209	CcSEcCtD
Docetaxel—Erythema—Epirubicin—stomach cancer	2.18e-05	0.000209	CcSEcCtD
Docetaxel—Nausea—Fluorouracil—stomach cancer	2.17e-05	0.000209	CcSEcCtD
Docetaxel—Eye disorder—Doxorubicin—stomach cancer	2.16e-05	0.000208	CcSEcCtD
Docetaxel—Anaemia—Methotrexate—stomach cancer	2.15e-05	0.000207	CcSEcCtD
Docetaxel—Cardiac disorder—Doxorubicin—stomach cancer	2.15e-05	0.000207	CcSEcCtD
Docetaxel—Flushing—Doxorubicin—stomach cancer	2.15e-05	0.000207	CcSEcCtD
Docetaxel—Dysgeusia—Epirubicin—stomach cancer	2.13e-05	0.000205	CcSEcCtD
Docetaxel—Back pain—Epirubicin—stomach cancer	2.11e-05	0.000203	CcSEcCtD
Docetaxel—Feeling abnormal—Capecitabine—stomach cancer	2.1e-05	0.000202	CcSEcCtD
Docetaxel—Angiopathy—Doxorubicin—stomach cancer	2.1e-05	0.000202	CcSEcCtD
Docetaxel—Muscle spasms—Epirubicin—stomach cancer	2.09e-05	0.000201	CcSEcCtD
Docetaxel—Immune system disorder—Doxorubicin—stomach cancer	2.09e-05	0.000201	CcSEcCtD
Docetaxel—Gastrointestinal pain—Capecitabine—stomach cancer	2.09e-05	0.000201	CcSEcCtD
Docetaxel—Mediastinal disorder—Doxorubicin—stomach cancer	2.09e-05	0.000201	CcSEcCtD
Docetaxel—Leukopenia—Methotrexate—stomach cancer	2.08e-05	0.0002	CcSEcCtD
Docetaxel—Chills—Doxorubicin—stomach cancer	2.08e-05	0.0002	CcSEcCtD
Docetaxel—Arrhythmia—Doxorubicin—stomach cancer	2.07e-05	0.000199	CcSEcCtD
Docetaxel—Alopecia—Doxorubicin—stomach cancer	2.04e-05	0.000197	CcSEcCtD
Docetaxel—Cough—Methotrexate—stomach cancer	2.03e-05	0.000195	CcSEcCtD
Docetaxel—Mental disorder—Doxorubicin—stomach cancer	2.03e-05	0.000195	CcSEcCtD
Docetaxel—Abdominal pain—Capecitabine—stomach cancer	2.02e-05	0.000194	CcSEcCtD
Docetaxel—Body temperature increased—Capecitabine—stomach cancer	2.02e-05	0.000194	CcSEcCtD
Docetaxel—Convulsion—Methotrexate—stomach cancer	2.02e-05	0.000194	CcSEcCtD
Docetaxel—Malnutrition—Doxorubicin—stomach cancer	2.01e-05	0.000194	CcSEcCtD
Docetaxel—Erythema—Doxorubicin—stomach cancer	2.01e-05	0.000194	CcSEcCtD
Docetaxel—Anaemia—Epirubicin—stomach cancer	2.01e-05	0.000194	CcSEcCtD
Docetaxel—Arthralgia—Methotrexate—stomach cancer	1.98e-05	0.000191	CcSEcCtD
Docetaxel—Chest pain—Methotrexate—stomach cancer	1.98e-05	0.000191	CcSEcCtD
Docetaxel—Myalgia—Methotrexate—stomach cancer	1.98e-05	0.000191	CcSEcCtD
Docetaxel—Dysgeusia—Doxorubicin—stomach cancer	1.97e-05	0.00019	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	1.97e-05	0.000189	CcSEcCtD
Docetaxel—Syncope—Epirubicin—stomach cancer	1.95e-05	0.000188	CcSEcCtD
Docetaxel—Leukopenia—Epirubicin—stomach cancer	1.95e-05	0.000187	CcSEcCtD
Docetaxel—Back pain—Doxorubicin—stomach cancer	1.95e-05	0.000187	CcSEcCtD
Docetaxel—Muscle spasms—Doxorubicin—stomach cancer	1.94e-05	0.000186	CcSEcCtD
Docetaxel—Palpitations—Epirubicin—stomach cancer	1.92e-05	0.000185	CcSEcCtD
Docetaxel—Confusional state—Methotrexate—stomach cancer	1.91e-05	0.000184	CcSEcCtD
Docetaxel—Loss of consciousness—Epirubicin—stomach cancer	1.91e-05	0.000184	CcSEcCtD
Docetaxel—Cough—Epirubicin—stomach cancer	1.9e-05	0.000183	CcSEcCtD
Docetaxel—Anaphylactic shock—Methotrexate—stomach cancer	1.9e-05	0.000183	CcSEcCtD
Docetaxel—Convulsion—Epirubicin—stomach cancer	1.89e-05	0.000181	CcSEcCtD
Docetaxel—Infection—Methotrexate—stomach cancer	1.89e-05	0.000181	CcSEcCtD
Docetaxel—Hypertension—Epirubicin—stomach cancer	1.88e-05	0.000181	CcSEcCtD
Docetaxel—Hypersensitivity—Capecitabine—stomach cancer	1.88e-05	0.000181	CcSEcCtD
Docetaxel—Nervous system disorder—Methotrexate—stomach cancer	1.86e-05	0.000179	CcSEcCtD
Docetaxel—Anaemia—Doxorubicin—stomach cancer	1.86e-05	0.000179	CcSEcCtD
Docetaxel—Thrombocytopenia—Methotrexate—stomach cancer	1.86e-05	0.000179	CcSEcCtD
Docetaxel—Arthralgia—Epirubicin—stomach cancer	1.85e-05	0.000178	CcSEcCtD
Docetaxel—Chest pain—Epirubicin—stomach cancer	1.85e-05	0.000178	CcSEcCtD
Docetaxel—Myalgia—Epirubicin—stomach cancer	1.85e-05	0.000178	CcSEcCtD
Docetaxel—Skin disorder—Methotrexate—stomach cancer	1.84e-05	0.000177	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	1.84e-05	0.000177	CcSEcCtD
Docetaxel—Asthenia—Capecitabine—stomach cancer	1.83e-05	0.000176	CcSEcCtD
Docetaxel—Dry mouth—Epirubicin—stomach cancer	1.81e-05	0.000174	CcSEcCtD
Docetaxel—Anorexia—Methotrexate—stomach cancer	1.81e-05	0.000174	CcSEcCtD
Docetaxel—Syncope—Doxorubicin—stomach cancer	1.81e-05	0.000174	CcSEcCtD
Docetaxel—Pruritus—Capecitabine—stomach cancer	1.8e-05	0.000174	CcSEcCtD
Docetaxel—Leukopenia—Doxorubicin—stomach cancer	1.8e-05	0.000173	CcSEcCtD
Docetaxel—Confusional state—Epirubicin—stomach cancer	1.79e-05	0.000172	CcSEcCtD
Docetaxel—Palpitations—Doxorubicin—stomach cancer	1.78e-05	0.000171	CcSEcCtD
Docetaxel—Anaphylactic shock—Epirubicin—stomach cancer	1.78e-05	0.000171	CcSEcCtD
Docetaxel—Oedema—Epirubicin—stomach cancer	1.78e-05	0.000171	CcSEcCtD
Docetaxel—Hypotension—Methotrexate—stomach cancer	1.77e-05	0.000171	CcSEcCtD
Docetaxel—Loss of consciousness—Doxorubicin—stomach cancer	1.77e-05	0.00017	CcSEcCtD
Docetaxel—Infection—Epirubicin—stomach cancer	1.77e-05	0.00017	CcSEcCtD
Docetaxel—Cough—Doxorubicin—stomach cancer	1.76e-05	0.000169	CcSEcCtD
Docetaxel—Shock—Epirubicin—stomach cancer	1.75e-05	0.000168	CcSEcCtD
Docetaxel—Convulsion—Doxorubicin—stomach cancer	1.75e-05	0.000168	CcSEcCtD
Docetaxel—Diarrhoea—Capecitabine—stomach cancer	1.75e-05	0.000168	CcSEcCtD
Docetaxel—Nervous system disorder—Epirubicin—stomach cancer	1.74e-05	0.000168	CcSEcCtD
Docetaxel—Thrombocytopenia—Epirubicin—stomach cancer	1.74e-05	0.000167	CcSEcCtD
Docetaxel—Hypertension—Doxorubicin—stomach cancer	1.74e-05	0.000167	CcSEcCtD
Docetaxel—Tachycardia—Epirubicin—stomach cancer	1.73e-05	0.000167	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Methotrexate—stomach cancer	1.73e-05	0.000166	CcSEcCtD
Docetaxel—Skin disorder—Epirubicin—stomach cancer	1.73e-05	0.000166	CcSEcCtD
Docetaxel—Insomnia—Methotrexate—stomach cancer	1.72e-05	0.000165	CcSEcCtD
Docetaxel—Chest pain—Doxorubicin—stomach cancer	1.71e-05	0.000165	CcSEcCtD
Docetaxel—Arthralgia—Doxorubicin—stomach cancer	1.71e-05	0.000165	CcSEcCtD
Docetaxel—Myalgia—Doxorubicin—stomach cancer	1.71e-05	0.000165	CcSEcCtD
Docetaxel—Paraesthesia—Methotrexate—stomach cancer	1.7e-05	0.000164	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	1.7e-05	0.000164	CcSEcCtD
Docetaxel—Anorexia—Epirubicin—stomach cancer	1.69e-05	0.000163	CcSEcCtD
Docetaxel—Dyspnoea—Methotrexate—stomach cancer	1.69e-05	0.000163	CcSEcCtD
Docetaxel—Somnolence—Methotrexate—stomach cancer	1.69e-05	0.000162	CcSEcCtD
Docetaxel—Dizziness—Capecitabine—stomach cancer	1.69e-05	0.000162	CcSEcCtD
Docetaxel—Dry mouth—Doxorubicin—stomach cancer	1.68e-05	0.000161	CcSEcCtD
Docetaxel—Dyspepsia—Methotrexate—stomach cancer	1.67e-05	0.000161	CcSEcCtD
Docetaxel—Hypotension—Epirubicin—stomach cancer	1.66e-05	0.00016	CcSEcCtD
Docetaxel—Confusional state—Doxorubicin—stomach cancer	1.66e-05	0.000159	CcSEcCtD
Docetaxel—Decreased appetite—Methotrexate—stomach cancer	1.65e-05	0.000159	CcSEcCtD
Docetaxel—Anaphylactic shock—Doxorubicin—stomach cancer	1.64e-05	0.000158	CcSEcCtD
Docetaxel—Oedema—Doxorubicin—stomach cancer	1.64e-05	0.000158	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Methotrexate—stomach cancer	1.64e-05	0.000158	CcSEcCtD
Docetaxel—Fatigue—Methotrexate—stomach cancer	1.64e-05	0.000157	CcSEcCtD
Docetaxel—Infection—Doxorubicin—stomach cancer	1.63e-05	0.000157	CcSEcCtD
Docetaxel—Pain—Methotrexate—stomach cancer	1.62e-05	0.000156	CcSEcCtD
Docetaxel—Vomiting—Capecitabine—stomach cancer	1.62e-05	0.000156	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Epirubicin—stomach cancer	1.62e-05	0.000156	CcSEcCtD
Docetaxel—Shock—Doxorubicin—stomach cancer	1.62e-05	0.000156	CcSEcCtD
Docetaxel—Nervous system disorder—Doxorubicin—stomach cancer	1.61e-05	0.000155	CcSEcCtD
Docetaxel—Thrombocytopenia—Doxorubicin—stomach cancer	1.61e-05	0.000155	CcSEcCtD
Docetaxel—Rash—Capecitabine—stomach cancer	1.61e-05	0.000155	CcSEcCtD
Docetaxel—Insomnia—Epirubicin—stomach cancer	1.61e-05	0.000155	CcSEcCtD
Docetaxel—Dermatitis—Capecitabine—stomach cancer	1.61e-05	0.000155	CcSEcCtD
Docetaxel—Tachycardia—Doxorubicin—stomach cancer	1.6e-05	0.000154	CcSEcCtD
Docetaxel—Headache—Capecitabine—stomach cancer	1.6e-05	0.000154	CcSEcCtD
Docetaxel—Skin disorder—Doxorubicin—stomach cancer	1.6e-05	0.000154	CcSEcCtD
Docetaxel—Paraesthesia—Epirubicin—stomach cancer	1.6e-05	0.000153	CcSEcCtD
Docetaxel—Dyspnoea—Epirubicin—stomach cancer	1.58e-05	0.000152	CcSEcCtD
Docetaxel—Somnolence—Epirubicin—stomach cancer	1.58e-05	0.000152	CcSEcCtD
Docetaxel—Anorexia—Doxorubicin—stomach cancer	1.57e-05	0.000151	CcSEcCtD
Docetaxel—Feeling abnormal—Methotrexate—stomach cancer	1.56e-05	0.000151	CcSEcCtD
Docetaxel—Dyspepsia—Epirubicin—stomach cancer	1.56e-05	0.00015	CcSEcCtD
Docetaxel—Gastrointestinal pain—Methotrexate—stomach cancer	1.55e-05	0.000149	CcSEcCtD
Docetaxel—Decreased appetite—Epirubicin—stomach cancer	1.54e-05	0.000149	CcSEcCtD
Docetaxel—Hypotension—Doxorubicin—stomach cancer	1.54e-05	0.000148	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Epirubicin—stomach cancer	1.53e-05	0.000148	CcSEcCtD
Docetaxel—Fatigue—Epirubicin—stomach cancer	1.53e-05	0.000147	CcSEcCtD
Docetaxel—Constipation—Epirubicin—stomach cancer	1.52e-05	0.000146	CcSEcCtD
Docetaxel—Pain—Epirubicin—stomach cancer	1.52e-05	0.000146	CcSEcCtD
Docetaxel—Nausea—Capecitabine—stomach cancer	1.51e-05	0.000146	CcSEcCtD
Docetaxel—Body temperature increased—Methotrexate—stomach cancer	1.5e-05	0.000144	CcSEcCtD
Docetaxel—Abdominal pain—Methotrexate—stomach cancer	1.5e-05	0.000144	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Doxorubicin—stomach cancer	1.5e-05	0.000144	CcSEcCtD
Docetaxel—Insomnia—Doxorubicin—stomach cancer	1.49e-05	0.000143	CcSEcCtD
Docetaxel—Paraesthesia—Doxorubicin—stomach cancer	1.48e-05	0.000142	CcSEcCtD
Docetaxel—Dyspnoea—Doxorubicin—stomach cancer	1.47e-05	0.000141	CcSEcCtD
Docetaxel—Feeling abnormal—Epirubicin—stomach cancer	1.46e-05	0.000141	CcSEcCtD
Docetaxel—Somnolence—Doxorubicin—stomach cancer	1.46e-05	0.000141	CcSEcCtD
Docetaxel—Gastrointestinal pain—Epirubicin—stomach cancer	1.45e-05	0.00014	CcSEcCtD
Docetaxel—Dyspepsia—Doxorubicin—stomach cancer	1.45e-05	0.000139	CcSEcCtD
Docetaxel—Decreased appetite—Doxorubicin—stomach cancer	1.43e-05	0.000137	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Doxorubicin—stomach cancer	1.42e-05	0.000137	CcSEcCtD
Docetaxel—Fatigue—Doxorubicin—stomach cancer	1.42e-05	0.000136	CcSEcCtD
Docetaxel—Pain—Doxorubicin—stomach cancer	1.41e-05	0.000135	CcSEcCtD
Docetaxel—Constipation—Doxorubicin—stomach cancer	1.41e-05	0.000135	CcSEcCtD
Docetaxel—Abdominal pain—Epirubicin—stomach cancer	1.4e-05	0.000135	CcSEcCtD
Docetaxel—Body temperature increased—Epirubicin—stomach cancer	1.4e-05	0.000135	CcSEcCtD
Docetaxel—Hypersensitivity—Methotrexate—stomach cancer	1.4e-05	0.000135	CcSEcCtD
Docetaxel—Asthenia—Methotrexate—stomach cancer	1.36e-05	0.000131	CcSEcCtD
Docetaxel—Feeling abnormal—Doxorubicin—stomach cancer	1.35e-05	0.00013	CcSEcCtD
Docetaxel—Gastrointestinal pain—Doxorubicin—stomach cancer	1.34e-05	0.000129	CcSEcCtD
Docetaxel—Pruritus—Methotrexate—stomach cancer	1.34e-05	0.000129	CcSEcCtD
Docetaxel—Hypersensitivity—Epirubicin—stomach cancer	1.31e-05	0.000126	CcSEcCtD
Docetaxel—Abdominal pain—Doxorubicin—stomach cancer	1.3e-05	0.000125	CcSEcCtD
Docetaxel—Body temperature increased—Doxorubicin—stomach cancer	1.3e-05	0.000125	CcSEcCtD
Docetaxel—Diarrhoea—Methotrexate—stomach cancer	1.3e-05	0.000125	CcSEcCtD
Docetaxel—Asthenia—Epirubicin—stomach cancer	1.27e-05	0.000123	CcSEcCtD
Docetaxel—Pruritus—Epirubicin—stomach cancer	1.26e-05	0.000121	CcSEcCtD
Docetaxel—Dizziness—Methotrexate—stomach cancer	1.26e-05	0.000121	CcSEcCtD
Docetaxel—Diarrhoea—Epirubicin—stomach cancer	1.22e-05	0.000117	CcSEcCtD
Docetaxel—Hypersensitivity—Doxorubicin—stomach cancer	1.21e-05	0.000117	CcSEcCtD
Docetaxel—Vomiting—Methotrexate—stomach cancer	1.21e-05	0.000116	CcSEcCtD
Docetaxel—Rash—Methotrexate—stomach cancer	1.2e-05	0.000115	CcSEcCtD
Docetaxel—Dermatitis—Methotrexate—stomach cancer	1.2e-05	0.000115	CcSEcCtD
Docetaxel—Headache—Methotrexate—stomach cancer	1.19e-05	0.000114	CcSEcCtD
Docetaxel—Asthenia—Doxorubicin—stomach cancer	1.18e-05	0.000113	CcSEcCtD
Docetaxel—Dizziness—Epirubicin—stomach cancer	1.17e-05	0.000113	CcSEcCtD
Docetaxel—Pruritus—Doxorubicin—stomach cancer	1.16e-05	0.000112	CcSEcCtD
Docetaxel—Vomiting—Epirubicin—stomach cancer	1.13e-05	0.000109	CcSEcCtD
Docetaxel—Nausea—Methotrexate—stomach cancer	1.13e-05	0.000108	CcSEcCtD
Docetaxel—Diarrhoea—Doxorubicin—stomach cancer	1.12e-05	0.000108	CcSEcCtD
Docetaxel—Rash—Epirubicin—stomach cancer	1.12e-05	0.000108	CcSEcCtD
Docetaxel—Dermatitis—Epirubicin—stomach cancer	1.12e-05	0.000108	CcSEcCtD
Docetaxel—Headache—Epirubicin—stomach cancer	1.11e-05	0.000107	CcSEcCtD
Docetaxel—Dizziness—Doxorubicin—stomach cancer	1.09e-05	0.000105	CcSEcCtD
Docetaxel—Nausea—Epirubicin—stomach cancer	1.06e-05	0.000102	CcSEcCtD
Docetaxel—Vomiting—Doxorubicin—stomach cancer	1.05e-05	0.000101	CcSEcCtD
Docetaxel—Rash—Doxorubicin—stomach cancer	1.04e-05	9.97e-05	CcSEcCtD
Docetaxel—Dermatitis—Doxorubicin—stomach cancer	1.04e-05	9.96e-05	CcSEcCtD
Docetaxel—Headache—Doxorubicin—stomach cancer	1.03e-05	9.91e-05	CcSEcCtD
Docetaxel—Nausea—Doxorubicin—stomach cancer	9.77e-06	9.39e-05	CcSEcCtD
Docetaxel—EGFR—Disease—IRS2—stomach cancer	1.67e-06	2.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PRKCB—stomach cancer	1.67e-06	2.07e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—HMOX1—stomach cancer	1.67e-06	2.06e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6ST—stomach cancer	1.67e-06	2.06e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ERCC2—stomach cancer	1.66e-06	2.05e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—HMOX1—stomach cancer	1.65e-06	2.05e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ENO1—stomach cancer	1.64e-06	2.03e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALDOB—stomach cancer	1.63e-06	2.02e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6ST—stomach cancer	1.63e-06	2.02e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—FBP1—stomach cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CA1—stomach cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CKB—stomach cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6R—stomach cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CAV1—stomach cancer	1.62e-06	2.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APOA1—stomach cancer	1.62e-06	2e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ALB—stomach cancer	1.61e-06	1.99e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ERCC2—stomach cancer	1.61e-06	1.99e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STAT3—stomach cancer	1.6e-06	1.98e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—stomach cancer	1.59e-06	1.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—stomach cancer	1.58e-06	1.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ADRB2—stomach cancer	1.58e-06	1.95e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TYMS—stomach cancer	1.57e-06	1.95e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.57e-06	1.94e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—APC—stomach cancer	1.57e-06	1.94e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—MTHFR—stomach cancer	1.56e-06	1.93e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TYMS—stomach cancer	1.56e-06	1.93e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GSTM1—stomach cancer	1.56e-06	1.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MAPK3—stomach cancer	1.55e-06	1.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PPP2R1A—stomach cancer	1.55e-06	1.91e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GSTM1—stomach cancer	1.54e-06	1.91e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—NOS3—stomach cancer	1.54e-06	1.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6ST—stomach cancer	1.54e-06	1.9e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MAPK3—stomach cancer	1.53e-06	1.89e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PLIN2—stomach cancer	1.53e-06	1.89e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALOX5—stomach cancer	1.52e-06	1.88e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.52e-06	1.88e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—MTHFR—stomach cancer	1.51e-06	1.87e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—DPYD—stomach cancer	1.49e-06	1.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CASP8—stomach cancer	1.49e-06	1.84e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CA2—stomach cancer	1.49e-06	1.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6R—stomach cancer	1.49e-06	1.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MAPK1—stomach cancer	1.48e-06	1.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APC—stomach cancer	1.48e-06	1.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDH1—stomach cancer	1.47e-06	1.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—RHOA—stomach cancer	1.47e-06	1.82e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ERCC2—stomach cancer	1.46e-06	1.81e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.46e-06	1.81e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MAPK1—stomach cancer	1.46e-06	1.8e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—stomach cancer	1.46e-06	1.8e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6R—stomach cancer	1.46e-06	1.8e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CD44—stomach cancer	1.45e-06	1.8e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PGAM1—stomach cancer	1.45e-06	1.79e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NT5E—stomach cancer	1.45e-06	1.79e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ERCC2—stomach cancer	1.45e-06	1.79e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CAV1—stomach cancer	1.44e-06	1.78e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—APOA1—stomach cancer	1.44e-06	1.78e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SMAD4—stomach cancer	1.44e-06	1.77e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—stomach cancer	1.41e-06	1.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—stomach cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CAV1—stomach cancer	1.39e-06	1.72e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—APOA1—stomach cancer	1.39e-06	1.72e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PLCE1—stomach cancer	1.38e-06	1.71e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.38e-06	1.71e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.38e-06	1.7e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—stomach cancer	1.38e-06	1.7e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—MTHFR—stomach cancer	1.37e-06	1.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6R—stomach cancer	1.37e-06	1.7e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SERPINE1—stomach cancer	1.36e-06	1.68e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—MTHFR—stomach cancer	1.36e-06	1.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FYN—stomach cancer	1.36e-06	1.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—stomach cancer	1.34e-06	1.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—stomach cancer	1.34e-06	1.66e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.33e-06	1.65e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—UMPS—stomach cancer	1.33e-06	1.64e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTT1—stomach cancer	1.32e-06	1.63e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—RHOA—stomach cancer	1.31e-06	1.63e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP2A6—stomach cancer	1.31e-06	1.61e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOS3—stomach cancer	1.3e-06	1.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL8—stomach cancer	1.29e-06	1.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—stomach cancer	1.29e-06	1.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SERPINE1—stomach cancer	1.28e-06	1.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PIK3CA—stomach cancer	1.28e-06	1.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGFR2—stomach cancer	1.28e-06	1.58e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKR1C3—stomach cancer	1.27e-06	1.57e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CAV1—stomach cancer	1.27e-06	1.57e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARG—stomach cancer	1.27e-06	1.57e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—APOA1—stomach cancer	1.27e-06	1.56e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PIK3CA—stomach cancer	1.26e-06	1.56e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CAV1—stomach cancer	1.26e-06	1.55e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—APOA1—stomach cancer	1.25e-06	1.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB2—stomach cancer	1.24e-06	1.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—RHOA—stomach cancer	1.24e-06	1.53e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ENO1—stomach cancer	1.24e-06	1.53e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPP2R1A—stomach cancer	1.24e-06	1.53e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PDHA1—stomach cancer	1.23e-06	1.53e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ECHS1—stomach cancer	1.23e-06	1.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PIK3CA—stomach cancer	1.23e-06	1.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOS3—stomach cancer	1.23e-06	1.52e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARG—stomach cancer	1.23e-06	1.51e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB2—stomach cancer	1.22e-06	1.5e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTP1—stomach cancer	1.21e-06	1.5e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HMOX1—stomach cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—stomach cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—stomach cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IRS2—stomach cancer	1.17e-06	1.45e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—stomach cancer	1.17e-06	1.45e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TYMP—stomach cancer	1.16e-06	1.43e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—FADS1—stomach cancer	1.16e-06	1.43e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.16e-06	1.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1B—stomach cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—stomach cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—stomach cancer	1.14e-06	1.41e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALB—stomach cancer	1.14e-06	1.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—stomach cancer	1.14e-06	1.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CAV1—stomach cancer	1.14e-06	1.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APOA1—stomach cancer	1.13e-06	1.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1B—stomach cancer	1.13e-06	1.4e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TYMS—stomach cancer	1.13e-06	1.39e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1B—stomach cancer	1.13e-06	1.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—stomach cancer	1.12e-06	1.39e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—stomach cancer	1.12e-06	1.38e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARG—stomach cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTM1—stomach cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARG—stomach cancer	1.11e-06	1.37e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALB—stomach cancer	1.1e-06	1.36e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CD44—stomach cancer	1.1e-06	1.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—JUN—stomach cancer	1.1e-06	1.35e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—NOS3—stomach cancer	1.09e-06	1.35e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SREBF2—stomach cancer	1.09e-06	1.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PRKCB—stomach cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6ST—stomach cancer	1.08e-06	1.33e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—RORA—stomach cancer	1.07e-06	1.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1B—stomach cancer	1.06e-06	1.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1A—stomach cancer	1.06e-06	1.31e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—NOS3—stomach cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ERCC2—stomach cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1A—stomach cancer	1.04e-06	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK8—stomach cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APC—stomach cancer	1.03e-06	1.28e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALDOB—stomach cancer	1.01e-06	1.24e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALB—stomach cancer	1e-06	1.24e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—stomach cancer	9.97e-07	1.23e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALB—stomach cancer	9.94e-07	1.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK3—stomach cancer	9.91e-07	1.22e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MTHFR—stomach cancer	9.85e-07	1.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1A—stomach cancer	9.8e-07	1.21e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—stomach cancer	9.64e-07	1.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6R—stomach cancer	9.61e-07	1.19e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—NOS3—stomach cancer	9.59e-07	1.19e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—NOS3—stomach cancer	9.5e-07	1.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—stomach cancer	9.48e-07	1.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK1—stomach cancer	9.43e-07	1.17e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALOX5—stomach cancer	9.35e-07	1.16e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPP2R1A—stomach cancer	9.33e-07	1.15e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—stomach cancer	9.28e-07	1.15e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—DPYD—stomach cancer	9.2e-07	1.14e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTP1—stomach cancer	9.15e-07	1.13e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CAV1—stomach cancer	9.09e-07	1.12e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—APOA1—stomach cancer	9.07e-07	1.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK3—stomach cancer	9.05e-07	1.12e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HMOX1—stomach cancer	9.03e-07	1.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SERPINE1—stomach cancer	9e-07	1.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—stomach cancer	8.9e-07	1.1e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK3—stomach cancer	8.87e-07	1.1e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—stomach cancer	8.77e-07	1.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—stomach cancer	8.75e-07	1.08e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—stomach cancer	8.69e-07	1.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RHOA—stomach cancer	8.68e-07	1.07e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—stomach cancer	8.67e-07	1.07e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—stomach cancer	8.63e-07	1.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK1—stomach cancer	8.61e-07	1.06e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOS3—stomach cancer	8.59e-07	1.06e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TYMS—stomach cancer	8.51e-07	1.05e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK1—stomach cancer	8.44e-07	1.04e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—stomach cancer	8.44e-07	1.04e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTM1—stomach cancer	8.41e-07	1.04e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK3—stomach cancer	8.36e-07	1.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—stomach cancer	8.18e-07	1.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—stomach cancer	8.14e-07	1.01e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTT1—stomach cancer	8.14e-07	1.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—stomach cancer	8.13e-07	1.01e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2A6—stomach cancer	8.04e-07	9.94e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—stomach cancer	8.03e-07	9.93e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARG—stomach cancer	7.99e-07	9.87e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—stomach cancer	7.97e-07	9.85e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK1—stomach cancer	7.95e-07	9.83e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ERCC2—stomach cancer	7.91e-07	9.78e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKR1C3—stomach cancer	7.82e-07	9.67e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ENO1—stomach cancer	7.62e-07	9.42e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—stomach cancer	7.62e-07	9.42e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—stomach cancer	7.57e-07	9.36e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—stomach cancer	7.51e-07	9.29e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—stomach cancer	7.47e-07	9.24e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1B—stomach cancer	7.44e-07	9.2e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MTHFR—stomach cancer	7.43e-07	9.19e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—stomach cancer	7.32e-07	9.05e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—stomach cancer	7.24e-07	8.96e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALB—stomach cancer	7.18e-07	8.88e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—stomach cancer	7.1e-07	8.77e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—JUN—stomach cancer	7.08e-07	8.76e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—stomach cancer	6.92e-07	8.55e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—stomach cancer	6.9e-07	8.53e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—stomach cancer	6.89e-07	8.52e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NOS3—stomach cancer	6.87e-07	8.49e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1A—stomach cancer	6.87e-07	8.49e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CAV1—stomach cancer	6.86e-07	8.48e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOA1—stomach cancer	6.84e-07	8.46e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—stomach cancer	6.77e-07	8.37e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CD44—stomach cancer	6.76e-07	8.36e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK8—stomach cancer	6.7e-07	8.28e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—stomach cancer	6.62e-07	8.18e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—stomach cancer	6.48e-07	8.02e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—stomach cancer	6.39e-07	7.89e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—stomach cancer	6.28e-07	7.77e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—stomach cancer	6.19e-07	7.65e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—stomach cancer	6.13e-07	7.58e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—stomach cancer	6.13e-07	7.57e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—stomach cancer	6.11e-07	7.55e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARG—stomach cancer	6.03e-07	7.45e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—stomach cancer	5.93e-07	7.33e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK3—stomach cancer	5.85e-07	7.24e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPP2R1A—stomach cancer	5.75e-07	7.11e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—stomach cancer	5.69e-07	7.04e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTP1—stomach cancer	5.64e-07	6.97e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK1—stomach cancer	5.57e-07	6.88e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HMOX1—stomach cancer	5.56e-07	6.87e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALB—stomach cancer	5.42e-07	6.7e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—stomach cancer	5.4e-07	6.67e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—stomach cancer	5.35e-07	6.61e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—stomach cancer	5.26e-07	6.5e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TYMS—stomach cancer	5.24e-07	6.48e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NOS3—stomach cancer	5.18e-07	6.41e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTM1—stomach cancer	5.18e-07	6.41e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ERCC2—stomach cancer	4.87e-07	6.02e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—stomach cancer	4.83e-07	5.97e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—stomach cancer	4.74e-07	5.86e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—stomach cancer	4.68e-07	5.78e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MTHFR—stomach cancer	4.58e-07	5.66e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—stomach cancer	4.47e-07	5.53e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—stomach cancer	4.28e-07	5.29e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CAV1—stomach cancer	4.22e-07	5.22e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOA1—stomach cancer	4.21e-07	5.21e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—stomach cancer	3.87e-07	4.78e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARG—stomach cancer	3.71e-07	4.59e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALB—stomach cancer	3.34e-07	4.13e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NOS3—stomach cancer	3.19e-07	3.95e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—stomach cancer	2.92e-07	3.61e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—stomach cancer	2.92e-07	3.61e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.8e-07	2.22e-06	CbGpPWpGaD
